Literature DB >> 20677217

Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle.

Ira J Smith1, Zaira Aversa, Nima Alamdari, Victoria Petkova, Per-Olof Hasselgren.   

Abstract

Myostatin is a negative regulator of muscle mass and has been reported to be upregulated in several conditions characterized by muscle atrophy. The influence of sepsis on myostatin expression and activity is poorly understood. Here, we tested the hypothesis that sepsis upregulates the expression and downstream signaling of myostatin in skeletal muscle. Because sepsis-induced muscle wasting is at least in part regulated by glucocorticoids, we also determined the influence of glucocorticoids on myostatin expression. Sepsis was induced in rats by cecal ligation and puncture and control rats were sham-operated. In other experiments, rats were injected intraperitoneally with dexamethasone (10 mg/kg) or corresponding volume of vehicle. Surprisingly, myostatin mRNA levels were reduced and myostatin protein levels were unchanged in muscles from septic rats. Muscle levels of activin A, follistatin, and total and phosphorylated Smad2 (p-Smad2) were not influenced by sepsis, suggesting that myostatin downstream signaling was not altered during sepsis. Interestingly, total and p-Smad3 levels were increased in septic muscle, possibly reflecting altered signaling through pathways other than myostatin. Similar to sepsis, treatment of rats with dexamethasone reduced myostatin mRNA levels and did not alter myostatin protein levels. Fasting, an additional condition characterized by muscle wasting, reduced myostatin mRNA and activin A protein levels, increased myostatin protein, and did not influence follistatin and p-Smad2 levels. Of note, total and p-Smad3 levels were reduced in muscle during fasting. The results suggest that sepsis and glucocorticoids do not upregulate the expression and activity of myostatin in skeletal muscle. The role of myostatin may vary between different conditions characterized by muscle wasting. Downstream signaling through Smad2 and 3 is probably regulated not only by myostatin but by other mechanisms as well.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20677217     DOI: 10.1002/jcb.22796

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

1.  Postsurgical Acute Phase Reaction is Associated with Decreased Levels of Circulating Myostatin.

Authors:  Torbjörn Åkerfeldt; Johanna Helmersson-Karlqvist; Lena Gunningberg; Christine Leo Swenne; Anders Larsson
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

2.  Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy.

Authors:  Estibaliz Castillero; Hirokazu Akashi; Catherine Wang; Marc Najjar; Ruiping Ji; Peter J Kennel; H Lee Sweeney; Paul C Schulze; Isaac George
Journal:  Biochem Biophys Res Commun       Date:  2014-12-18       Impact factor: 3.575

3.  Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness.

Authors:  Nima Alamdari; Gianluca Toraldo; Zaira Aversa; Ira Smith; Estibaliz Castillero; Guillaume Renaud; Rizwan Qaisar; Lars Larsson; Ravi Jasuja; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-09-26       Impact factor: 3.619

4.  Effect of postdevelopmental myostatin depletion on myofibrillar protein metabolism.

Authors:  Stephen Welle; Sangeeta Mehta; Kerri Burgess
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-03-15       Impact factor: 4.310

Review 5.  Muscle wasting in disease: molecular mechanisms and promising therapies.

Authors:  Shenhav Cohen; James A Nathan; Alfred L Goldberg
Journal:  Nat Rev Drug Discov       Date:  2015-01       Impact factor: 84.694

6.  Preliminary investigation into a potential role for myostatin and its receptor (ActRIIB) in lean and obese horses and ponies.

Authors:  Philippa K Morrison; Chen Bing; Patricia A Harris; Charlotte A Maltin; Dai Grove-White; Caroline McG Argo
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

7.  Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α.

Authors:  Yuko Ono; Kazuho Sakamoto
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

8.  Analysis of a gene regulatory cascade mediating circadian rhythm in zebrafish.

Authors:  Ying Li; Guang Li; Haifang Wang; Jiulin Du; Jun Yan
Journal:  PLoS Comput Biol       Date:  2013-02-28       Impact factor: 4.475

9.  PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting.

Authors:  Estibaliz Castillero; Nima Alamdari; Zaira Aversa; Aniket Gurav; Per-Olof Hasselgren
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.752

10.  Aerobic exercise + weight loss decreases skeletal muscle myostatin expression and improves insulin sensitivity in older adults.

Authors:  A S Ryan; G Li; J B Blumenthal; H K Ortmeyer
Journal:  Obesity (Silver Spring)       Date:  2013-05-19       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.